The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
H pylori antibiotic resistance: prevalence, importance, and advances in testing
Open accessAbstract
he discovery that Helicobacter pylori infection is the main cause of most gastroduodenal diseases has been a major breakthrough in gastroenterology.It has dramatically changed the management of these diseases which are now considered as infectious diseases and are treated with antibiotics.Triple therapy, including two antibiotics, amoxicillin and clarithromycin, and a proton pump inhibitor given for a week has been recommended as the treatment of choice at several consensus conferences.[1][2][3][4][5][6] However, this treatment may fail for several reasons, as reported elsewhere.7 In fact, the main reason for failure was found to be H pylori resistance to one of the antibiotics used (that is, clarithromycin).Other treatments have also been proposed, including metronidazole, a drug for which resistance is also a problem although to a lesser extent, as well as tetracycline, fluoroquinolones, and rifamycins for which resistance has become an emerging issue.8 9 Our aim was to review the prevalence of H pylori resistance to these various antibiotics, their clinical importance, and methods of testing, especially in light of the resistance mechanism which allows application of molecular methods.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Malfertheiner, P., Mégraud, F., O'Morain, C., Hungin, A. P. S., Jones, R., Axon, A., Graham, D. Y., Tytgat, G., & The European Helicobacter Pylori Study Group (EHPSG) (2002) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2002.01169.x · Cited by 1,237
Self-citationMalfertheiner, P., Mégraud, F., OʼMorain, C., Bell, D., Porro, B. G., Deltenre, M., Forman, D., Gasbarrini, G., Jaup, B., Misiewicz, J. J., et al. (1997) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-199701000-00002 · Cited by 980
Self-citationThe LightCycler TM : A Microvolume Multisample Fluorimeter with Rapid Temperature Control
Wittwer, C. T., Ririe, K. M., Andrew, R. V., David, D. A., Gundry, R. A., & Balis, U. J. (1997) · BioTechniques · doi:10.2144/97221pf02 · Cited by 893
Variation in antibiotic use in the European Union
Cars, O., Mölstad, S., & Melander, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04972-2 · Cited by 698
Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori
Versalovic, J., Shortridge, D., Kibler, K., Griffy, M. V., Beyer, J., Flamm, R. K., Tanaka, S. K., Graham, D. Y., & Go, M. F. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.2.477 · Cited by 501
Helicobacter Pylori: Physiology and Genetics
Mobley, H. L. T., Mendz, G. L., & Hazell, S. L. (2001) · Cited by 441
Lind, T., Mégraud, F., Unge, P., Bayerdörffer, E., O'Morain, C., Spiller, R., van Zanten, S. V., Bardhan, K. D., Hellblom, M., Wrangstadh, M., et al. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70119-8 · Cited by 434
Self-citationLAM, S., & TALLEY, N. (1998) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.1998.tb00537.x · Cited by 424
Houben, Beek, D. V. D., Hensen, Craen, A. J. M. D., Rauws, & Tytgat (1999) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1999.00555.x · Cited by 333
Cited by
Malfertheiner, P., Megraud, F., O'Morain, C., Bazzoli, F., El-Omar, E., Graham, D., Hunt, R., Rokkas, T., Vakil, N., Kuipers, E. J., et al. (2007) · Gut · doi:10.1136/gut.2006.101634 · Cited by 2,240
Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report
Malfertheiner, P., Megraud, F., Rokkas, T., Gisbert, J. P., Liou, J.-M., Schulz, C., Gasbarrini, A., Hunt, R. H., Leja, M., O'Morain, C., et al. (2022) · Gut · doi:10.1136/gutjnl-2022-327745 · Cited by 1,533
Savoldi, A., Carrara, E., Graham, D. Y., Conti, M., & Tacconelli, E. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.07.007 · Cited by 1,270
Helicobacter pylori treatment in the era of increasing antibiotic resistance
Graham, D. Y., & Fischbach, L. (2010) · Gut · doi:10.1136/gut.2009.192757 · Cited by 1,028
Megraud, F., Coenen, S., Versporten, A., Kist, M., Lopez-Brea, M., Hirschl, A. M., Andersen, L. P., Goossens, H., Glupczynski, Y., & on behalf of the Study Group participants (2013) · Gut · doi:10.1136/gutjnl-2012-302254 · Cited by 839
Review article: the global emergence of Helicobacter pylori antibiotic resistance
Thung, I., Aramin, H., Vavinskaya, V., Gupta, S., Park, J. Y., Crowe, S. E., & Valasek, M. A. (2016) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13497 · Cited by 743
Helicobacter pylori Detection and Antimicrobial Susceptibility Testing
Mégraud, F., & Lehours, P. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00033-06 · Cited by 725
Cock, I., Cheesman, M., Ilanko, A., & Blonk, B. (2017) · Pharmacognosy Reviews · doi:10.4103/phrev.phrev_21_17 · Cited by 550
Malfertheiner, P., Bazzoli, F., Delchier, J.-C., Celiñski, K., Giguère, M., Rivière, M., & Mégraud, F. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60020-2 · Cited by 523
Self-citationHelicobacter pylori and antimicrobial resistance: molecular mechanisms and clinical implications
Gerrits, M. M., van Vliet, A. H., Kuipers, E. J., & Kusters, J. G. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70627-2 · Cited by 329
Kuo, Y.-T., Liou, J.-M., El-Omar, E. M., Wu, J.-Y., Leow, A. H. R., Goh, K. L., Das, R., Lu, H., Lin, J.-T., Tu, Y.-K., et al. (2017) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(17)30219-4 · Cited by 319
Megraud, F., Bruyndonckx, R., Coenen, S., Wittkop, L., Huang, T.-D., Hoebeke, M., Bénéjat, L., Lehours, P., Goossens, H., & Glupczynski, Y. (2021) · Gut · doi:10.1136/gutjnl-2021-324032 · Cited by 291
Treatment of Helicobacter pylori Infection
O'Connor, A., Gisbert, J., & O’Morain, C. (2009) · Helicobacter · doi:10.1111/j.1523-5378.2009.00704.x · Cited by 281
Fucoidans Disrupt Adherence of Helicobacter pylori to AGS Cells In Vitro
Chua, E.-G., Verbrugghe, P., Perkins, T. T., & Tay, C.-Y. (2015) · Evidence-Based Complementary and Alternative Medicine · doi:10.1155/2015/120981 · Cited by 273
Bacteriophage and their lysins for elimination of infectious bacteria
O'Flaherty, S., Ross, R. P., & Coffey, A. (2009) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2009.00176.x · Cited by 272
Vaira, D., Zullo, A., Vakil, N., Gatta, L., Ricci, C., Perna, F., Hassan, C., Bernabucci, V., Tampieri, A., & Morini, S. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-8-200704170-00006 · Cited by 266
Sequential Therapy versus Standard Triple-Drug Therapy for Helicobacter pylori Eradication
(2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-8-200704170-00002 · Cited by 262
Saad, R. J., Schoenfeld, P., Kim, H. M., & Chey, W. D. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00637.x · Cited by 261
Greenberg, E. R., Anderson, G. L., Morgan, D. R., Torres, J., Chey, W. D., Bravo, L. E., Dominguez, R. L., Ferreccio, C., Herrero, R., Lazcano-Ponce, E. C., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60825-8 · Cited by 257
Metadata
- Authors
- Mégraud, F.
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2004-08-11
- Volume
- 53
- Issue
- 9
- Pages
- 1374-1384
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- OpenAlex
- W2136210283
- Cited by
- 955
- References
- 63
- FWCI
- 29.99
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.